CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Day One Biopharmaceuticals - DAWN CFD

    11.89
    3.21%
    0.08
    Low: 11.33
    High: 11.97
    Market Trading Hours* (UTC) Open now
    Closes on Friday at 21:00

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.08
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Day One Biopharmaceuticals Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 11.54
    Open* 11.33
    1-Year Change* -46.43%
    Day's Range* 11.33 - 11.97
    52 wk Range 9.67-25.77
    Average Volume (10 days) 558.59K
    Average Volume (3 months) 17.95M
    Market Cap 1.04B
    P/E Ratio -100.00K
    Shares Outstanding 87.04M
    Revenue N/A
    EPS -2.30
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 30, 2023 11.54 -0.16 -1.37% 11.70 12.18 11.50
    Nov 29, 2023 11.54 -0.03 -0.26% 11.57 12.14 11.54
    Nov 28, 2023 11.54 -0.05 -0.43% 11.59 11.68 11.39
    Nov 27, 2023 11.60 -0.28 -2.36% 11.88 11.96 11.42
    Nov 24, 2023 12.01 0.45 3.89% 11.56 12.25 11.54
    Nov 22, 2023 11.82 0.00 0.00% 11.82 12.09 11.77
    Nov 21, 2023 11.89 0.31 2.68% 11.58 12.12 11.41
    Nov 20, 2023 12.09 0.03 0.25% 12.06 12.39 11.96
    Nov 17, 2023 12.11 0.68 5.95% 11.43 12.24 11.42
    Nov 16, 2023 11.67 -0.05 -0.43% 11.72 11.97 11.35
    Nov 15, 2023 12.04 0.06 0.50% 11.98 12.42 11.94
    Nov 14, 2023 12.13 0.66 5.75% 11.47 12.16 11.47
    Nov 13, 2023 11.36 0.48 4.41% 10.88 11.41 10.81
    Nov 10, 2023 11.30 0.17 1.53% 11.13 11.37 10.85
    Nov 9, 2023 11.18 -0.70 -5.89% 11.88 11.99 11.13
    Nov 8, 2023 12.11 0.00 0.00% 12.11 12.54 11.88
    Nov 7, 2023 12.31 0.28 2.33% 12.03 12.72 11.79
    Nov 6, 2023 12.15 -0.57 -4.48% 12.72 12.87 12.11
    Nov 3, 2023 12.70 0.63 5.22% 12.07 12.84 12.06
    Nov 2, 2023 11.99 0.31 2.65% 11.68 12.06 11.65

    Day One Biopharmaceuticals Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total revenue 0 0 0 0
    Total Operating Expense 146.909 72.743 13.782 14.905
    Selling/General/Admin. Expenses, Total 61.291 29.159 4.682 1.006
    Research & Development 85.618 43.584 9.1 13.899
    Operating Income -146.909 -72.743 -13.782 -14.905
    Interest Income (Expense), Net Non-Operating 4.746 0.004 -30.03 -2.077
    Other, Net -0.018 -0.015 -0.031 -0.002
    Net Income Before Taxes -142.181 -72.754 -43.843 -16.984
    Net Income After Taxes -142.181 -72.754 -43.843 -16.984
    Minority Interest 0 -97.885 3.336 4.35
    Net Income Before Extra. Items -142.181 -170.639 -40.507 -12.634
    Net Income -142.181 -170.639 -40.507 -12.634
    Income Available to Common Excl. Extra. Items -142.181 -170.639 -40.507 -12.634
    Income Available to Common Incl. Extra. Items -142.181 -170.639 -40.507 -12.634
    Diluted Net Income -142.181 -170.639 -40.507 -12.634
    Diluted Weighted Average Shares 65.4668 36.9606 60.3374 60.3374
    Diluted EPS Excluding Extraordinary Items -2.1718 -4.61678 -0.67134 -0.20939
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -2.1718 -4.61678 -0.67134 -0.20939
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0 0 0 0 0
    Total Operating Expense 49.254 45.855 42.743 39.699 36.719
    Selling/General/Admin. Expenses, Total 17.072 18.027 16.723 17.664 14.159
    Research & Development 32.182 27.828 26.02 22.035 22.56
    Operating Income -49.254 -45.855 -42.743 -39.699 -36.719
    Interest Income (Expense), Net Non-Operating 3.406 3.466 2.66 1.895 0.189
    Other, Net -0.015 -0.004 -0.026 0.009 0
    Net Income Before Taxes -45.863 -42.393 -40.109 -37.795 -36.53
    Net Income After Taxes -45.863 -42.393 -40.109 -37.795 -36.53
    Minority Interest 0 0 0
    Net Income Before Extra. Items -45.863 -42.393 -40.109 -37.795 -36.53
    Net Income -45.863 -42.393 -40.109 -37.795 -36.53
    Income Available to Common Excl. Extra. Items -45.863 -42.393 -40.109 -37.795 -36.53
    Income Available to Common Incl. Extra. Items -45.863 -42.393 -40.109 -37.795 -36.53
    Diluted Net Income -45.863 -42.393 -40.109 -37.795 -36.53
    Diluted Weighted Average Shares 74.9649 71.9729 71.2988 71.009 60.7605
    Diluted EPS Excluding Extraordinary Items -0.61179 -0.58901 -0.56255 -0.53226 -0.60121
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.61179 -0.58901 -0.56255 -0.53226 -0.60121
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total Current Assets 347.874 289.368 45.071 27.339
    Cash and Short Term Investments 342.269 284.309 43.728 27.332
    Cash 85.262 284.309 43.728 27.332
    Prepaid Expenses 5.605 5.059 1.343 0.007
    Total Assets 349.062 289.821 45.661 27.339
    Total Current Liabilities 16.615 8.657 1.996 2.021
    Accounts Payable 0.26 1.744 0.202 0.069
    Accrued Expenses 16.176 6.809 1.767 0.466
    Notes Payable/Short Term Debt 0 0 0 0
    Other Current Liabilities, Total 0.179 0.104 0.027 1.486
    Total Liabilities 17.023 8.673 7.902 7.508
    Total Long Term Debt 0 0 0 0
    Minority Interest 0 5.702 5.487
    Other Liabilities, Total 0.408 0.016 0.204 0
    Total Equity 332.039 281.148 37.759 19.831
    Redeemable Preferred Stock 0 91.964 30.504
    Common Stock 0.007 0.006 2.637 2.111
    Retained Earnings (Accumulated Deficit) -269.668 -127.487 -56.842 -12.784
    Total Liabilities & Shareholders’ Equity 349.062 289.821 45.661 27.339
    Total Common Shares Outstanding 73.4582 61.9523 60.3374 60.3374
    Property/Plant/Equipment, Total - Net 0.719 0.284 0.483
    Property/Plant/Equipment, Total - Gross 0.725 0.32 0.499
    Accumulated Depreciation, Total -0.006 -0.036 -0.016
    Long Term Investments 0.469 0.169 0.107
    Additional Paid-In Capital 601.771 408.629
    Short Term Investments 257.007
    Other Equity, Total -0.071
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 413.291 449.784 322.388 347.874 380.513
    Cash and Short Term Investments 405.538 442.882 318.179 342.269 374.341
    Cash 241.179 189.211 49.268 85.262 120.864
    Prepaid Expenses 7.753 6.902 4.209 5.605 6.172
    Total Assets 414.179 450.756 323.563 349.062 381.861
    Property/Plant/Equipment, Total - Net 0.655 0.713 0.688 0.719 0.899
    Property/Plant/Equipment, Total - Gross 0.685 0.731 0.7 0.725 0.982
    Accumulated Depreciation, Total -0.03 -0.018 -0.012 -0.006 -0.083
    Long Term Investments 0.233 0.259 0.487 0.469 0.449
    Total Current Liabilities 24.475 24.512 22.848 16.615 18.271
    Accounts Payable 3.391 4.565 4.657 0.26 3.973
    Accrued Expenses 20.675 19.761 17.676 16.176 13.845
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.409 0.186 0.515 0.179 0.453
    Total Liabilities 24.552 24.702 23.148 17.023 18.785
    Total Long Term Debt 0 0 0 0 0
    Minority Interest
    Other Liabilities, Total 0.077 0.19 0.3 0.408 0.514
    Total Equity 389.627 426.054 300.415 332.039 363.076
    Redeemable Preferred Stock
    Common Stock 0.009 0.009 0.007 0.007 0.007
    Retained Earnings (Accumulated Deficit) -404.074 -357.924 -312.061 -269.668 -229.559
    Total Liabilities & Shareholders’ Equity 414.179 450.756 323.563 349.062 381.861
    Total Common Shares Outstanding 87.0429 86.9713 73.5726 73.4582 73.5119
    Additional Paid-In Capital 793.699 783.978 612.402 601.771 593.02
    Short Term Investments 164.359 253.671 268.911 257.007 253.477
    Other Equity, Total -0.007 -0.009 0.067 -0.071 -0.392
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Net income/Starting Line -142.181 -72.754 -43.843 -16.984
    Cash From Operating Activities -109.874 -48.539 -13.489 -4.515
    Cash From Operating Activities 0.063 0.02 0.016 0
    Non-Cash Items 25.68 21.5 30.695 12.025
    Changes in Working Capital 6.564 2.695 -0.357 0.444
    Cash From Investing Activities -255.074 -8 -0.092 0
    Capital Expenditures -0.026 0 -0.092 0
    Cash From Financing Activities 165.901 297.12 29.977 30.905
    Financing Cash Flow Items 0 0 1
    Issuance (Retirement) of Stock, Net 165.901 297.12 29.977 29.905
    Net Change in Cash -199.047 240.581 16.396 26.39
    Other Investing Cash Flow Items, Total -255.048 -8
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -42.393 -142.181 -102.072 -64.277 -27.747
    Cash From Operating Activities -25.985 -109.874 -74.564 -51.35 -21.563
    Cash From Operating Activities 0.006 0.063 0.048 0.012 0.006
    Non-Cash Items 8.931 25.68 19.681 12.007 6.249
    Changes in Working Capital 7.471 6.564 7.779 0.908 -0.071
    Cash From Investing Activities -11.193 -255.074 -252.864 -6.012 -0.015
    Other Investing Cash Flow Items, Total -11.167 -255.048 -252.838 -5.99 0
    Cash From Financing Activities 1.184 165.901 163.983 161.93 0
    Financing Cash Flow Items 0 0
    Issuance (Retirement) of Stock, Net 1.184 165.901 163.983 161.93 0
    Net Change in Cash -35.994 -199.047 -163.445 104.568 -21.578
    Capital Expenditures -0.026 -0.026 -0.026 -0.022 -0.015
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Access Industries, Inc. Corporation 14.8658 12929322 1475454 2023-10-20 LOW
    RA Capital Management, LP Hedge Fund 8.9795 7809852 769230 2023-06-30 LOW
    Atlas Venture Venture Capital 8.7479 7608394 0 2023-06-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 7.0902 6166598 566826 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.9163 4275929 1143948 2023-06-30 LOW
    Franklin Advisers, Inc. Investment Advisor/Hedge Fund 4.6431 4038281 652697 2023-06-30 LOW
    Braidwell LP Hedge Fund 3.8653 3361813 201918 2023-06-30 HIGH
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.8567 3354326 1097535 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 3.7199 3235332 1168668 2023-06-30 LOW
    Viking Global Investors LP Investment Advisor/Hedge Fund 2.9418 2558563 1000000 2023-06-30 MED
    Canaan Partners Venture Capital 2.8647 2491561 -56842 2023-09-30 LOW
    Adage Capital Management, L.P. Hedge Fund 2.8083 2442500 1702500 2023-06-30 LOW
    Goldman Sachs & Company, Inc. Research Firm 2.6946 2343567 155187 2023-06-30 MED
    T. Rowe Price Associates, Inc. Investment Advisor 2.6353 2292007 640234 2023-06-30 LOW
    Nicholas Investment Partners, L.P. Investment Advisor/Hedge Fund 2.5722 2237111 633721 2023-06-30 MED
    Blackman (Samuel C) Individual Investor 2.5713 2236319 1956 2023-08-17 LOW
    Polar Capital LLP Investment Advisor/Hedge Fund 2.0404 1774615 375067 2023-06-30 LOW
    Fidelity Institutional Asset Management Investment Advisor 1.602 1393305 -1579106 2023-06-30 LOW
    Deerfield Management Company, L.P. Hedge Fund 1.4602 1269992 1269992 2023-06-30 MED
    Bender (Jeremy) Individual Investor 1.4572 1267372 5316 2023-08-17 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Day One Biopharmaceuticals Company profile

    Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
    Industry: Biotechnology & Medical Research (NEC)

    2000 Sierra Point Parkway, Suite 501
    BRISBANE
    CALIFORNIA 94005
    US

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    US100

    15,926.00 Price
    +0.160% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Oil - Crude

    76.26 Price
    +0.220% 1D Chg, %
    Long position overnight fee -0.0165%
    Short position overnight fee -0.0054%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    XRP/USD

    0.62 Price
    +0.200% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Gold

    2,058.65 Price
    +0.970% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading